Aplagon
aplagon.com
Actively hiring
Health Care
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Grants
$2.3M
1 grant · CORDIS
Backers
1
Innovestorgroup
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1, 2022
Won a grant $2.3M · CORDIS
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Grant | Sep 2022 | $2.3M | — | CORDIS |
Backed byfrom the funds' portfolios and accelerator catalogs
Innovestorgroup Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.
Therapeutic Ultrasound-Based Solution for Vascular Care. cardiovascular disease is VTE. ¹.
EpiEndo Pharmaceuticals. We are a clinical-stage biopharmaceutical company committed to developing oral drugs for chronic respiratory…
AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing…
SignaCor, a UK based, clinical stage biotech company are pioneering a first-in-class therapeutic approach to symptomatic hypertrophic…
At Block Biosciences, we are developing first-in-class therapeutics designed to intercept the spread of cancer to the brain.
Overview
About Us Aplagon is a clinical-stage biopharmaceutical company developing first-in-class therapeutics for a wide range of thromboinflammatory diseases. The Unmet Need Cardiovascular diseases carry significant morbidity and mortality.
Financials
Total raised
$2.3M
Latest round
Grant
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Grant | 2022 | $2.3M | Details |